These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25684493)

  • 1. Metformin association with lower prostate cancer recurrence in type 2 diabetes: a systematic review and meta-analysis.
    Hwang IC; Park SM; Shin D; Ahn HY; Rieken M; Shariat SF
    Asian Pac J Cancer Prev; 2015; 16(2):595-600. PubMed ID: 25684493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
    Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
    Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis.
    Tang GH; Satkunam M; Pond GR; Steinberg GR; Blandino G; Schünemann HJ; Muti P
    Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):627-635. PubMed ID: 29618465
    [No Abstract]   [Full Text] [Related]  

  • 4. Monotherapy with Metformin versus Sulfonylureas and Risk of Cancer in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis.
    Mekuria AN; Ayele Y; Tola A; Mishore KM
    J Diabetes Res; 2019; 2019():7676909. PubMed ID: 31828167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
    Zhang H; Gao C; Fang L; Zhao HC; Yao SK
    Scand J Gastroenterol; 2013 Jan; 48(1):78-87. PubMed ID: 23137049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
    Meng F; Song L; Wang W
    J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
    Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
    Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
    Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
    Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of metformin on mortality following cancer among patients with diabetes.
    Lega IC; Shah PS; Margel D; Beyene J; Rochon PA; Lipscombe LL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1974-84. PubMed ID: 25030683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
    Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin may improve the prognosis of patients with pancreatic cancer.
    Zhang JW; Sun Q
    Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of metformin intake with bladder cancer risk and oncologic outcomes in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
    Hu J; Chen JB; Cui Y; Zhu YW; Ren WB; Zhou X; Liu LF; Chen HQ; Zu XB
    Medicine (Baltimore); 2018 Jul; 97(30):e11596. PubMed ID: 30045293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.
    Nayan M; Punjani N; Juurlink DN; Finelli A; Austin PC; Kulkarni GS; Uleryk E; Hamilton RJ
    Am J Clin Oncol; 2019 Mar; 42(3):275-284. PubMed ID: 30663998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
    Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
    Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis.
    He K; Hu H; Ye S; Wang H; Cui R; Yi L
    Sci Rep; 2019 Feb; 9(1):2218. PubMed ID: 30778081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of metformin in patients with prostate cancer and the risk of death.
    Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2111-8. PubMed ID: 25017246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.